Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tucker

Showing results (311-320 of 348) with videos related to

Pageof 35
Sort By:
British Journal of Clinical Pharmacology|July 1, 1994
Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranololK Rowland, W W Yeo, S W Ellis, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humansBrian O'Mathúna, Magi Farré, Amin Rostami-Hodjegan, et al.
Journal of Pharmaceutical Sciences|August 23, 2012
Impact of the pharmaceutical sciences on health care: a reflection over the past 50 yearsMalcolm Rowland, Christian R Noe, Dennis A Smith, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The antitussive effect of dextromethorphan in relation to CYP2D6 activityR Abdul Manap, C E Wright, A Gregory, et al.
Virology|March 11, 2014
Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infectionJonathan Arzt, Juan M Pacheco, George R Smoliga, et al.
Biochemical Pharmacology|March 29, 1994
The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)G T Tucker, M S Lennard, S W Ellis, et al.
Journal of Pharmacological Methods|December 1, 1985
Assessment of an in situ rat intestine preparation with perfused vascular bed for studying the absorption and first-pass metabolism of drugsS J Castle, G T Tucker, H F Woods, et al.
The Journal of Biological Chemistry|December 8, 1995
Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6S W Ellis, G P Hayhurst, G Smith, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutantsR Mackman, R A Tschirret-Guth, G Smith, et al.
ACS Applied Materials & Interfaces|April 2, 2010
Electrostatic layer-by-layer assembly of CdSe nanorod/polymer nanocomposite thin filmsSean A McClure, Brian J Worfolk, David A Rider, et al.
Pageof 35

Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
British Journal of Clinical Pharmacology|July 1, 1994
Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranololK Rowland, W W Yeo, S W Ellis, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humansBrian O'Mathúna, Magi Farré, Amin Rostami-Hodjegan, et al.
Journal of Pharmaceutical Sciences|August 23, 2012
Impact of the pharmaceutical sciences on health care: a reflection over the past 50 yearsMalcolm Rowland, Christian R Noe, Dennis A Smith, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The antitussive effect of dextromethorphan in relation to CYP2D6 activityR Abdul Manap, C E Wright, A Gregory, et al.
Virology|March 11, 2014
Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infectionJonathan Arzt, Juan M Pacheco, George R Smoliga, et al.
Biochemical Pharmacology|March 29, 1994
The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)G T Tucker, M S Lennard, S W Ellis, et al.
Journal of Pharmacological Methods|December 1, 1985
Assessment of an in situ rat intestine preparation with perfused vascular bed for studying the absorption and first-pass metabolism of drugsS J Castle, G T Tucker, H F Woods, et al.
The Journal of Biological Chemistry|December 8, 1995
Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6S W Ellis, G P Hayhurst, G Smith, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutantsR Mackman, R A Tschirret-Guth, G Smith, et al.
ACS Applied Materials & Interfaces|April 2, 2010
Electrostatic layer-by-layer assembly of CdSe nanorod/polymer nanocomposite thin filmsSean A McClure, Brian J Worfolk, David A Rider, et al.
Pageof 35